Drug intelligence / Profile preview

NiVLP

Development stage
Preclinical
Lead developer
Sferogen
Modality
Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
01

Overview

NiVLP is a trivalent enveloped virus-like particle (eVLP) vaccine candidate developed by Sferogen for the prevention of Nipah virus infection. The vaccine utilizes Sferogen's proprietary eVLP platform to present multiple Nipah virus antigens in a structure that mimics the native virus but lacks the genetic material required for replication. By displaying these antigens in a highly organized, multivalent format, NiVLP is designed to induce potent neutralizing antibody and cellular immune responses. It is currently in preclinical development as part of Sferogen's pandemic preparedness pipeline, aimed at addressing the high mortality rate and outbreak potential of the Nipah virus.

Other names
NiVLP (trivalent)eVLP/Nipah virus vaccineNipah virus enveloped virus-like particle vaccine
02

Targets

NiV-G (Nipah virus attachment glycoprotein)

Beyond the preview

Go deeper on NiVLP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NiVLP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call